Lv6
2160 积分 2023-06-08 加入
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
11小时前
已完结
Tarlatamab: First Approval
11小时前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
11小时前
已完结
Discovery of epigenetic modulators targeting HDACs and EZH2 simultaneously for the treatment of hematological malignancies
12小时前
已完结
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study
12小时前
已完结
Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study
12小时前
已完结
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
12小时前
已完结
A review of the isocitrate dehydrogenase inhibitors in management of adult patients with AML and MDS
12小时前
已完结
Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study
13小时前
已完结
PARG inhibitor sensitivity correlates with accumulation of single-stranded DNA gaps in preclinical models of ovarian cancer
13小时前
已完结
皖公网安备34019202002308
